When a new celebrity skincare range launches, my first reaction is rarely excitement – it’s skepticism. And the latest? Dua Lipa’s collaboration with Augustinus Bader. On paper, it’s a powerhouse pairing: pop royalty meets biotech beauty. But somehow, it still doesn’t land.

Fragrance and makeup – that’s where celebrity brands work. They’re expressive, emotive, and entirely rooted in persona. A scent can tell you who you want to be for the night; a lipstick shade can feel like confidence in a bullet. These are spaces where celebrity allure belongs.

But skincare? That’s where things get murky. Skincare lives in the world of trust, efficacy, and expertise – not charisma. It’s the quiet work of derms, scientists, and decades of formulation research. When celebrities step into that territory, the connection feels forced – like they’ve wandered out of their lane wearing someone else’s lab coat.

And we’ve seen this movie before. Madonna tried. Brad Pitt tried (and got plenty of backlash). Dozens have launched “clean,” “genderless,” “science-backed” lines that promise authenticity but deliver a diluted sense of credibility. The formulas might be fine, but the narrative just doesn’t stick – because consumers don’t believe it.

That’s not to say celebrity beauty shouldn’t exist. It absolutely should – but in the spaces that play to star power, not pseudo-science.

Skincare demands something else entirely: humility, authority, and results.

When it comes to these fluid and expressive industries, the risks are simply lower. Makeup and fragrance are experiential; skincare is consequential. A poor lipstick choice is reversible – a poor acid exfoliant isn’t. Consumers want assurances that someone has done the work – the trials, the stability testing, the safety profiling – not simply lent their image to it.

Authenticity is the buzzword of the moment, and consumers are more acutely aware than ever of the origins of a brand, the credibility behind a partnership, and the occasions where it feels more like hype than purposeful evolution. In 2025, credibility is earned through lived expertise, not borrowed authority. The skincare buyer has become too literate – and too sceptical – to accept a celebrity as their new skin mentor. Especially when we, the consumers, know full well that a celebrity of Dua Lipa’s status will have an army of facialists, dermatologists, and aesthetic doctors on hand to help her achieve her stunning starlet appearance.

And when it’s a brand like Augustinus Bader – built upon a firm foundation of clinical rigour, medical heritage, and decades of research – a celebrity collaboration of this nature risks diluting that carefully cultivated narrative.

Instead of elevating the brand, the celebrity halo can create a discontinuity between brand promise and brand behaviour.

That’s in addition to the question of why the brand feels the need to launch a more accessible price point at this time, when beauty’s middle ground of prestige brands is falling by the wayside in favour of those that deliver truly accessible value. The industry is polarising: consumers are moving decisively towards either the thrill of luxury or the clarity of value, leaving the so-called “prestige plateau” increasingly undefinable and unappealing. As spending becomes more intentional, anything that sits vaguely in the middle feels less necessary – and less defensible. So a brand like Augustinus Bader, positioned firmly at the luxury end with a narrative built on scientific rigour, risks confusing the consumer by suddenly reaching downwards. In a market where value-led efficacy is outperforming mid-tier offerings and luxury is free to become ever more exquisite and uncompromising, a move into the middle raises more questions than it answers.

Perhaps Dua missed a trick here – a “dual action” of art and allure, rather than science and skincare. Because as talented and magnetic as she is, no one’s asking Dua Lipa to solve their barrier function.